Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/27/2025

Oral Cavity Cancer Management

Initial Workup and Staging

  • Clinical examination with rigid head and neck endoscopy under general anesthesia is mandatory for all patients, as per the Annals of Oncology guidelines 1, 2
  • Contrast-enhanced CT and/or MRI of the head and neck is required to assess primary tumor extent and depth of invasion (DOI) 1, 2
  • Chest imaging with CT and/or FDG-PET is necessary to evaluate for distant metastases 1, 2
  • Pathological confirmation via biopsy is required before initiating treatment, as recommended by the Annals of Oncology 1
  • Endoscopic ultrasound is an option if early-stage disease is suspected, according to the Journal of the National Comprehensive Cancer Network 3
  • Pre-treatment assessment must include nutritional status with weight assessment, as per the Annals of Oncology guidelines 1, 4
  • Dental examination with rehabilitation planning is necessary if radiotherapy is anticipated, as recommended by the Annals of Oncology 1, 4
  • Cardiopulmonary and renal function evaluation is required, according to the Annals of Oncology 4
  • Performance status and comorbidity assessment is necessary, as per the Annals of Oncology guidelines 2, 4
  • Speech and swallowing function baseline is required, as recommended by the Annals of Oncology 2
  • If weight loss exceeds 10% in the 6 months before diagnosis, enteral nutrition via percutaneous gastrostomy should be initiated before starting treatment, according to the Annals of Oncology guidelines 1, 4

Primary Treatment by Stage

  • For early-stage oral cavity cancer, surgery is the primary treatment modality, with adjuvant therapy determined by pathologic risk factors, as per the Annals of Oncology guidelines 1
  • Wide local excision with 1 cm clinical margins is recommended for early-stage disease, as per the Annals of Oncology guidelines 1
  • Pathologic margins must achieve ≥5 mm clearance when possible, according to the Praxis Medical Insights guidelines 5
  • Depth of invasion (DOI) determines neck management, with DOI <5 mm and cT1N0 requiring active surveillance of the neck, as per the Annals of Oncology guidelines 1
  • For well-lateralized tongue tumors, ipsilateral selective neck dissection (levels I-IV) is appropriate, according to the Praxis Medical Insights guidelines 5
  • External beam radiotherapy or brachytherapy can be used as an alternative to surgery for selected stage I subsites, as per the Annals of Oncology guidelines 1
  • For locally advanced disease, surgery followed by risk-adapted adjuvant therapy is the standard approach, as per the Annals of Oncology guidelines 1, 6
  • Postoperative radiotherapy or chemoradiotherapy must begin within 6-7 weeks of surgery, with the entire treatment sequence completed within 11 weeks, as recommended by the Annals of Oncology guidelines 6, 9

Pathologic Assessment Requirements

  • Surgical specimens must be evaluated for tumor size and growth pattern, as per the Annals of Oncology guidelines 2, 4
  • Depth of invasion (DOI) is critical for oral cavity staging, as per the Annals of Oncology guidelines 1, 2
  • Total number of lymph nodes removed and number involved must be evaluated, as recommended by the Annals of Oncology guidelines 1, 2
  • Presence of extracapsular extension must be assessed, as per the Annals of Oncology guidelines 1, 2
  • Perineural and lymphatic infiltration must be evaluated, as recommended by the Annals of Oncology guidelines 1, 2
  • Surgical margin status (R0, R1, or R2) must be assessed, as per the Annals of Oncology guidelines 1, 2

Recurrent and Metastatic Disease

  • Treatment depends on prior therapy and PD-L1 status, as per the Annals of Oncology guidelines 6, 8, 9
  • For PD-L1-positive tumors, pembrolizumab monotherapy is recommended, with a median OS of 12.3-14.9 months, as per the Annals of Oncology guidelines 6, 8, 9
  • For PD-L1-negative tumors, pembrolizumab plus platinum/5-FU is recommended, with a median OS of 13 months, as per the Annals of Oncology guidelines 8, 9
  • Locoregional recurrence requires referral to a tertiary center for multidisciplinary evaluation of salvage surgery or re-irradiation, as recommended by the Annals of Oncology guidelines 8, 9

Surveillance Protocol

  • Follow-up schedule includes clinical examination with flexible endoscopy every 2-3 months for the first 2 years, as per the Annals of Oncology guidelines 6
  • Imaging includes baseline post-treatment imaging at 3 months for locally advanced disease, as recommended by the Annals of Oncology guidelines 6
  • FDG-PET/CT at 3 months post-chemoradiotherapy is necessary to assess the need for neck dissection, as per the Annals of Oncology guidelines 1, 6
  • Ancillary monitoring includes TSH levels every 6-12 months following neck irradiation, as recommended by the Praxis Medical Insights guidelines 5
  • Dental evaluation every 6 months is necessary for patients who received radiotherapy, as per the Annals of Oncology guidelines 6
  • Tobacco and alcohol cessation counseling is recommended, as per the Journal of the National Comprehensive Cancer Network guidelines 10

REFERENCES

3

gastric cancer, version 2.2025, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2025

5

Management of T1N0 Tongue Carcinoma with Perineural Invasion [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

9

nccn guidelines® insights: survivorship, version 2.2025. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2025